FDA staff question peptides backed by Kennedy ahead of advisory panel review

By Sneha S K June 30 (Reuters) - U.S. FDA staff reviewers said there is little evidence to allow compounding pharmacies to ...

Key FDA committee unanimously recommends its first vaccine since 2023

All nine members of the committee unanimously voted to recommend Moderna's new mRNA influenza vaccine for adults 50 and over.
STAT

Longevity, wellness physicians named to panel advising FDA on peptides

The Food and Drug Administration on Monday published the names of eight new panelists who will serve on a committee advising ...

RFK Jr. wants to make it easier to get peptides. FDA scientists disagree.

The health secretary has advocated for deregulating more peptides, but FDA scientists point to a lack of data about their ...
Healio

FDA advisory committee for peptides stocked with conflicts of interest

The FDA has listed its advisory members for the committee that will discuss peptides in late July. Owais Durrani, DO, an emergency medicine physician in Houston, previously wrote for Healio that “some ...
MedPage Today on MSN

FDA scientists raise peptide concerns ahead of committee meeting

RFK Jr. recently added peptide-friendly members to a key panel ...

Trump’s FDA may soon throw its weight behind peptides. Should you buy in?

An FDA hearing in late July may lead to a peptides boom. What consumers and investors need to know.
Money Morning

FDA Advisors Back Moderna's mRNA Flu Vaccine Unanimously: The Biggest Healthcare Move of Summer 2026

Your resource for the hottest moving stocks and news. We cover all sectors and markets giving everyday investors access to ...
Fierce Healthcare

FDA advisory committee to roll up sleeves on generative AI this week

The FDA has several advisory committees for topics within its regulatory purview. The independent experts offer advice and recommendations to the agency. (U.S. Food and Drug Administration) The FDA ...

Capricor Therapeutics Announces FDA Advisory Committee Meeting to Review BLA for Deramiocel for the Treatment of Duchenne Muscular Dystrophy

Company's Biologics License Application on track with PDUFA target action date of August 22, 2026– SAN DIEGO, June 26, 2026 ...
BioSpace

Capricor thrown for another loop as FDA sets adcomm for DMD cardiomyopathy therapy

The FDA plans to hold an advisory committee meeting to discuss Capricor Therapeutics’ application for deramiocel, which the agency rejected last July. The news surprised CEO Linda Marbán, who told ...
The BMJ

Peptides: FDA appointed advisory committee criticised for conflicts of interest

A committee of experts tasked with deciding if the US Food and Drug Administration (FDA) should loosen restrictions on peptides has members who stand to financially benefit from the move, critics have ...